Hypertension Journal

JANUARY 2, 2024

Hypertension, Ahead of Print. Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide.

Hypertension 40

Hypertension Blood Pressure Cerebrovascular Disease Risk Factors 40

Circulation

DECEMBER 22, 2023

Dietary interventions are an effective approach to lower blood pressure (BP) but are not equally effective across all individuals. BP is heritable, and genetics may be a useful tool to overcome treatment response heterogeneity. Intervention studies are warranted.

Hypertension 45

Hypertension Blood Pressure Biomarkers Risk Factors 45

Circulation: Heart Failure

MARCH 5, 2025

BACKGROUND:Exercise-induced hypertension (EIH) is common in adults with coarctation of the aorta (COA), but there are limited data about hemodynamics and outcomes in such patients. Circulation: Heart Failure, Ahead of Print.

Exercise 40

Exercise Hypertension Outcomes Biomarkers 40

Frontiers in Cardiovascular Medicine

FEBRUARY 18, 2025

Abnormal stress biomarkers [regional wall motion abnormalities (RWMAs), ST-segment depression, induced angina, peak systolic blood pressure, force-based contractile reserve (CR), heart rate reserve (HRR), and low exercise capacity] were used for phenotyping.

Chest Pain 52

Chest Pain Exercise Angina Coronary Artery Disease 52

Hypertension Journal

DECEMBER 11, 2024

Hypertension, Ahead of Print. BACKGROUND:Renin-independent aldosterone production in normotensive people increases risk for developing hypertension. These findings provide mechanistic explanations to implicate PA in the pathogenesis of a substantial proportion of hypertension.

Blood Pressure 40

Blood Pressure Biomarkers Hypertension 40

The British Journal of Cardiology

JUNE 11, 2024

Additionally, 2D transthoracic echocardiography (TTE), and myocardial injury serum biomarkers assays (creatine phosphokinase-MB [CPK-MB] and cardiac troponins [cTn]) were measured once. New-onset high systolic and diastolic blood pressures were seen in 67 patients (10%).

COVID-19 40

COVID-19 Cardiovascular Disease Angina Chest Pain 40

Stroke Journal

JANUARY 30, 2025

Patients with increasing CT-CSVD scores were older (p<0.001), more likely to have hypertension (p<0.001), diabetes (p<0.001), coronary artery disease (p=0.044), and a higher baseline systolic blood pressure (p=0.037). 1.02; score 2: OR 0.46, 95%CI 0.26-0.83; 0.83; score 3: OR 0.16, 95%CI 0.03-0.76,

Thrombolysis 40

Thrombolysis Outcomes Biomarkers Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Other significant risk markers included systolic blood pressure, hypertension, estimated glomerular filtration rate, metabolic syndrome, and blood sugar level. This study presents a data-driven machine-learning framework for stroke risk prediction and biomarker identification.

Stroke 40

Stroke Strokes Blood Pressure Laboratory 40

Dr. Smith's ECG Blog

DECEMBER 14, 2016

The blood pressure was 110/60. The patient had no hypertension, no tachycardia, a normal hemoglobin, no drug use, no hypotension/shock, no murmur of aortic stenosis. It was not relieved by anything. The pain was not positional, pleuritic, or reproducible. He had no previous medical history. If it is MI, is it type 1 or type 2?

Chest Pain 52

Chest Pain STEMI Aortic Myocardial Infarction 52

Physiologically Speaking

MARCH 29, 2024

In a new study, evening exercise, but not morning exercise, reduced blood pressure, lowered sympathetic activity, and improved baroreflex sensitivity in a group of adults with treated hypertension. VO 2 max), body composition, and diastolic blood pressure. “When is the best time to exercise?

Blood Pressure 52

Blood Pressure Exercise Physiology Hypertension 52

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

IntroductionThe COVID-19 pandemic, starting in 2020, raised concerns about potential long-term health impacts, including its effects on cardiovascular health and related biomarkers. The study observed modest declines in mean glucose, cholesterol, HDL, and LDL levels post-pandemic, with stable blood pressure.

COVID-19 52

COVID-19 Blood Pressure Cholesterol Biomarkers 52

Journal of the American Heart Association

FEBRUARY 14, 2024

BackgroundThiazide diuretics are the second most frequently prescribed class of antihypertensives, but up to 50% of patients with hypertension have minimal antihypertensive response to thiazides. 0.9]) associated with categorical diastolic blood pressure response at Benjamini‐Hochberg adjustedP<0.05. miRNAs with ≥2.5‐fold

Biomarkers 45

Biomarkers Circulation Hypertension Blood Pressure 45

Stroke Journal

FEBRUARY 1, 2024

Neurodegenerative plasma biomarkers may be associated with cognitive decline via vascular processes causing higher WMHv such as cerebral amyloid angiopathy & inflammatory small vessel disease. Conclusion:There were no significant adjusted associations between any plasma biomarker with CR.

Blood Pressure 40

Blood Pressure Biomarkers Education Hypertension 40

Journal of the American Heart Association

DECEMBER 29, 2023

BackgroundLow‐grade systemic inflammation is a relevant pathogenic mechanism underlying the development of hypertension. Participants with hypertension at baseline were excluded. 0.66) mg/L, and median systolic blood pressure was 117 (109–126) mm Hg. Median plasma calprotectin levels were 0.48 (0.34–0.66) 1.11];P=0.996).

Hypertension 40

Hypertension Blood Pressure Biomarkers 40

Dr. Smith's ECG Blog

DECEMBER 11, 2023

Her systolic blood pressure at the dentist was over 200 mm Hg. She was given nitroglycerin which improved her blood pressure, and she completed the procedure. The neighbor recorded a systolic blood pressure again above 200 mm Hg and advised her to come to the ED to address her symptoms. Her arm pain abated.

Myocardial Infarction 122

Myocardial Infarction Chest Pain STEMI Blood Pressure 122

Stroke Journal

FEBRUARY 1, 2024

Due to conflicting prior studies, it is uncertain if the degree of systolic blood pressure reduction increases the risk. Patients with severe, chronic hypertension may be more vulnerable to the development of ischemia after ICH due to altered cerebral autoregulatory limits. and LVH was seen in 23.5%.

Hemorrhage 40

Hemorrhage Blood Pressure Hypertension Biomarkers 40

Frontiers in Cardiovascular Medicine

JANUARY 29, 2025

ObjectiveTo investigate the sex differences in the efficacy of renal denervation (RDN) in patients with resistant hypertension (RHT) concerning the size of abdominal fat depots, changes in biomarkers of sympathetic activity, and renal function.Materials and methods24 men (56.57.8 years) and 33 women (59.58.4

Obesity 52

Obesity Hypertension Kidney Disease Blood Pressure 52

Hypertension Journal

SEPTEMBER 21, 2023

Hypertension, Ahead of Print. Recently, some randomized trials, including the SPRINT (Systolic Blood Pressure Intervention Trial), have suggested that improvements in cardiovascular risk factors may also slow cognitive decline and reduce the eventual development of dementia.

Dementia 40

Dementia Cardiovascular Interventions Blood Pressure Physiology 40

Stroke Journal

JANUARY 30, 2025

In a linear regression model adjusted for age, sex, race, hypertension, diabetes, prior stroke, current smoking, current alcohol use, systolic blood pressure, and APOE genotype, lower eGFR was significantly associated with higher WMH ( = -0.008; 95% CI -0.013, -0.003; p < 0.001) (Figure 2). female, 22.1%

Atherosclerosis 40

Atherosclerosis Kidney Disease Blood Pressure Biomarkers 40

Open Heart

AUGUST 16, 2023

Objective To characterise cardiac remodelling, exercise capacity and fibroinflammatory biomarkers in patients with aortic stenosis (AS) with and without diabetes, and assess the impact of diabetes on outcomes. Results Diabetes (n=56) and non-diabetes groups (n=198) were well matched for age, sex, ethnicity, blood pressure and severity of AS.

Exercise 52

Exercise Diabetes Stenosis Aortic 52

Physiologically Speaking

APRIL 24, 2024

6 [link] Insufficient sleep has been linked to a greater risk for several health conditions including obesity, diabetes, hypertension, and cognitive decline. The amount of calcium in the blood vessels (known as arterial calcification), a marker of subclinical atherosclerosis, is higher in people with a short sleep duration.

Blood Pressure 52

Blood Pressure Blood Clot COVID-19 Cardiovascular Disease 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Part 1: Concepts, Indicator Variables, and Controversies The Annals of Thoracic Surgery January 2022 Arman Kilic Supplementing Existing Societal Risk Models for Surgical Aortic Valve Replacement With Machine Learning for Improved Prediction Journal of the American Heart Association November 2021 Jared Belle Strategies for Mechanical Right Ventricular (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Physiologically Speaking

DECEMBER 17, 2024

While CAC is typically associated with traditional risk factors such as age, hypertension, and smoking, paradoxically elevated CAC scores have been observed in male endurance athletes despite their otherwise healthy profiles. Coronary artery calcium (CAC) is a measure of atherosclerosis and a strong predictor of cardiovascular disease.

Risk Factors 105

Risk Factors Genetic predisposition Plaque Exercise 105

Cardiometabolic Health Congress

NOVEMBER 14, 2024

42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. In the U.S., SELECT Trial Results : Semaglutide 2.4

CME 103

CME Obesity Heart Failure Biomarkers 103